Contact Us
Drug Search Results
More Filters [+]

Fosaprepitant

Alternative Names: fosaprepitant, mk-0517, mk0517, mk 0517
Latest Update: 2024-12-18
Latest Update Note: Clinical Trial Update

Product Description

a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting (Sourced from: https://pubmed.ncbi.nlm.nih.gov/18983233/)

Mechanisms of Action: NK1 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Austria | Belgium | Brazil | Canada | China | Colombia | Croatia | Dominican Republic | Egypt | Estonia | Germany | Hong Kong | Hungary | India | Italy | Japan | Malaysia | Mexico | Netherlands | New Zealand | Norway | Philippines | Russia | South Africa | Spain | Taiwan | Thailand | Turkey | United Arab Emirates | United Kingdom | United States | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Merck
Company Location: KENILWORTH NJ 07033
Company CEO: Robert M. Davis
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fosaprepitant

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Oncology Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2018-000663-80

P3

Active, not recruiting

Oncology Unspecified

2019-05-11

Recent News Events

Date

Type

Title

10/10/2024

News Article

 Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids

09/23/2024

News Article

 Avenacy to Share Company's Year One Progress at CPHI Milan 2024

07/29/2024

News Article

 Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags

07/09/2024

News Article

 Amneal Launches FOCINVEZ™, the First Ready-to-Use Version of Fosaprepitant

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions